Global COVID-19 Inactivated Vaccine Market Size, Status and Forecast 2022
SKU ID : QYR-19772640 | Publishing Date : 23-Dec-2021 | No. of pages : 128
Detailed TOC of Global COVID-19 Inactivated Vaccine Market Size, Status and Forecast 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type (2021-2027)
1.2.2 In Clinical Trials
1.2.3 Out-of-Clinical Trials
1.3 Market by Application
1.3.1 Global COVID-19 Inactivated Vaccine Market Share by Application (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global COVID-19 Inactivated Vaccine Market Size
2.2 COVID-19 Inactivated Vaccine Market Size by Regions
2.2.1 COVID-19 Inactivated Vaccine Growth Rate by Regions (2021-2027)
2.2.2 COVID-19 Inactivated Vaccine Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 COVID-19 Inactivated Vaccine Revenue by Players (2020-2021)
3.2 COVID-19 Inactivated Vaccine Key Players Headquaters and Area Served
3.3 Key Players COVID-19 Inactivated Vaccine Product/Solution/Service
3.4 Date of Enter into COVID-19 Inactivated Vaccine Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global COVID-19 Inactivated Vaccine Market Size by Type (2021-2027)
4.2 Global COVID-19 Inactivated Vaccine Market Size by Application (2021-2027)
5 North America
5.1 North America COVID-19 Inactivated Vaccine Market Forecast (2021-2027)
5.2 COVID-19 Inactivated Vaccine Key Players in North America
5.3 North America COVID-19 Inactivated Vaccine Market Size by Type
5.4 North America COVID-19 Inactivated Vaccine Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe COVID-19 Inactivated Vaccine Market Forecast (2021-2027)
6.2 COVID-19 Inactivated Vaccine Key Players in Europe
6.3 Europe COVID-19 Inactivated Vaccine Market Size by Type
6.4 Europe COVID-19 Inactivated Vaccine Market Size by Application
7 Japan
7.1 Japan COVID-19 Inactivated Vaccine Market Forecast (2021-2027)
7.2 COVID-19 Inactivated Vaccine Key Players in Europe
7.3 Japan COVID-19 Inactivated Vaccine Market Size by Type
7.4 Japan COVID-19 Inactivated Vaccine Market Size by Application
8 Rest of World
8.1 China
8.1.1 China COVID-19 Inactivated Vaccine Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia COVID-19 Inactivated Vaccine Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India COVID-19 Inactivated Vaccine Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Inovio Pharmaceuticals
9.1.1 Inovio Pharmaceuticals Company Details
9.1.2 Inovio Pharmaceuticals Description and Business Overview
9.1.3 Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Introduction
9.1.4 Inovio Pharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.1.5 Inovio Pharmaceuticals Recent Development
9.2 Takis Biotech (Evvivax)
9.2.1 Takis Biotech (Evvivax) Company Details
9.2.2 Takis Biotech (Evvivax) Description and Business Overview
9.2.3 Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Introduction
9.2.4 Takis Biotech (Evvivax) Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.2.5 Takis Biotech (Evvivax) Recent Development
9.3 Zydus Cadila
9.3.1 Zydus Cadila Company Details
9.3.2 Zydus Cadila Description and Business Overview
9.3.3 Zydus Cadila COVID-19 Inactivated Vaccine Introduction
9.3.4 Zydus Cadila Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.3.5 Zydus Cadila Recent Development
9.4 Codagenix, Inc.
9.4.1 Codagenix, Inc. Company Details
9.4.2 Codagenix, Inc. Description and Business Overview
9.4.3 Codagenix, Inc. COVID-19 Inactivated Vaccine Introduction
9.4.4 Codagenix, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.4.5 Codagenix, Inc. Recent Development
9.5 GeoVax, Inc.
9.5.1 GeoVax, Inc. Company Details
9.5.2 GeoVax, Inc. Description and Business Overview
9.5.3 GeoVax, Inc. COVID-19 Inactivated Vaccine Introduction
9.5.4 GeoVax, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.5.5 GeoVax, Inc. Recent Development
9.6 Bravovax
9.6.1 Bravovax Company Details
9.6.2 Bravovax Description and Business Overview
9.6.3 Bravovax COVID-19 Inactivated Vaccine Introduction
9.6.4 Bravovax Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.6.5 Bravovax Recent Development
9.7 Janssen Pharmaceutical Companies
9.7.1 Janssen Pharmaceutical Companies Company Details
9.7.2 Janssen Pharmaceutical Companies Description and Business Overview
9.7.3 Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Introduction
9.7.4 Janssen Pharmaceutical Companies Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.7.5 Janssen Pharmaceutical Companies Recent Development
9.8 Altimmune
9.8.1 Altimmune Company Details
9.8.2 Altimmune Description and Business Overview
9.8.3 Altimmune COVID-19 Inactivated Vaccine Introduction
9.8.4 Altimmune Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.8.5 Altimmune Recent Development
9.9 Vaxart
9.9.1 Vaxart Company Details
9.9.2 Vaxart Description and Business Overview
9.9.3 Vaxart COVID-19 Inactivated Vaccine Introduction
9.9.4 Vaxart Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.9.5 Vaxart Recent Development
9.10 CanSino Biologics
9.10.1 CanSino Biologics Company Details
9.10.2 CanSino Biologics Description and Business Overview
9.10.3 CanSino Biologics COVID-19 Inactivated Vaccine Introduction
9.10.4 CanSino Biologics Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.10.5 CanSino Biologics Recent Development
9.11 ExpreS2ion Biotechnologies ApS
9.11.1 ExpreS2ion Biotechnologies ApS Company Details
9.11.2 ExpreS2ion Biotechnologies ApS Description and Business Overview
9.11.3 ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Introduction
9.11.4 ExpreS2ion Biotechnologies ApS Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.11.5 ExpreS2ion Biotechnologies ApS Recent Development
9.12 Clover Biopharmaceuticals
9.12.1 Clover Biopharmaceuticals Company Details
9.12.2 Clover Biopharmaceuticals Description and Business Overview
9.12.3 Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Introduction
9.12.4 Clover Biopharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.12.5 Clover Biopharmaceuticals Recent Development
9.13 GSK
9.13.1 GSK Company Details
9.13.2 GSK Description and Business Overview
9.13.3 GSK COVID-19 Inactivated Vaccine Introduction
9.13.4 GSK Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.13.5 GSK Recent Development
9.14 Vaxil Bio Ltd.
9.14.1 Vaxil Bio Ltd. Company Details
9.14.2 Vaxil Bio Ltd. Description and Business Overview
9.14.3 Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Introduction
9.14.4 Vaxil Bio Ltd. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.14.5 Vaxil Bio Ltd. Recent Development
9.15 Generex
9.15.1 Generex Company Details
9.15.2 Generex Description and Business Overview
9.15.3 Generex COVID-19 Inactivated Vaccine Introduction
9.15.4 Generex Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.15.5 Generex Recent Development
9.16 Novavax, Inc.
9.16.1 Company Details
9.16.2 Novavax, Inc. Description and Business Overview
9.16.3 Novavax, Inc. COVID-19 Inactivated Vaccine Introduction
9.16.4 Novavax, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.16.5 Novavax, Inc. Recent Development
9.17 Sanofi Pasteur
9.17.1 Sanofi Pasteur Company Details
9.17.2 Sanofi Pasteur Description and Business Overview
9.17.3 Sanofi Pasteur COVID-19 Inactivated Vaccine Introduction
9.17.4 Sanofi Pasteur Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.17.5 Sanofi Pasteur Recent Development
9.18 Baylor
9.18.1 Baylor Company Details
9.18.2 Baylor Description and Business Overview
9.18.3 Baylor COVID-19 Inactivated Vaccine Introduction
9.18.4 Baylor Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.18.5 Baylor Recent Development
9.19 iBio, Inc.
9.19.1 iBio, Inc. Company Details
9.19.2 iBio, Inc. Description and Business Overview
9.19.3 iBio, Inc. COVID-19 Inactivated Vaccine Introduction
9.19.4 iBio, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.19.5 iBio, Inc. Recent Development
9.20 Moderna, Inc.
9.20.1 Moderna, Inc. Company Details
9.20.2 Moderna, Inc. Description and Business Overview
9.20.3 Moderna, Inc. COVID-19 Inactivated Vaccine Introduction
9.20.4 Moderna, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.20.5 Moderna, Inc. Recent Development
9.21 Curevac
9.21.1 Curevac Company Details
9.21.2 Curevac Description and Business Overview
9.21.3 Curevac COVID-19 Inactivated Vaccine Introduction
9.21.4 Curevac Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.21.5 Curevac Recent Development
9.22 ImmunoPrecise
9.22.1 ImmunoPrecise Company Details
9.22.2 ImmunoPrecise Description and Business Overview
9.22.3 ImmunoPrecise COVID-19 Inactivated Vaccine Introduction
9.22.4 ImmunoPrecise Revenue in COVID-19 Inactivated Vaccine Business (2020-2021)
9.22.5 ImmunoPrecise Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of Figures, Tables and Charts Available in Global COVID-19 Inactivated Vaccine Market Size, Status and Forecast 2022
List of TablesTable 1. Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of In Clinical Trials
Table 3. Key Players of Out-of-Clinical Trials
Table 4. Global COVID-19 Inactivated Vaccine Market Size Growth by Application (2021-2027) (US$ Million)
Table 5. Global COVID-19 Inactivated Vaccine Market Size by Regions (2021-2027) (US$ Million)
Table 6. Global COVID-19 Inactivated Vaccine Market Share by Regions (2021-2027)
Table 7. Market Top Trends
Table 8. Market Use Cases
Table 9. Global COVID-19 Inactivated Vaccine Revenue by Players (2020-2021) (US$ Million)
Table 10. Global COVID-19 Inactivated Vaccine Market Share by Players (2020-2021)
Table 11. Key Players Headquarters and Area Served
Table 12. Key Players COVID-19 Inactivated Vaccine Product Solution and Service
Table 13. Date of Enter into COVID-19 Inactivated Vaccine Market
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Global COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 16. Global COVID-19 Inactivated Vaccine Market Size Share by Type (2021-2027)
Table 17. Global COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 18. Global COVID-19 Inactivated Vaccine Market Size Share by Application (2021-2027)
Table 19. North America Key Players COVID-19 Inactivated Vaccine Revenue (2020-2021) (US$ Million)
Table 20. North America Key Players COVID-19 Inactivated Vaccine Market Share (2020-2021)
Table 21. North America COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 22. North America COVID-19 Inactivated Vaccine Market Share by Type (2021-2027)
Table 23. North America COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 24. North America COVID-19 Inactivated Vaccine Market Share by Application (2021-2027)
Table 25. Europe Key Players COVID-19 Inactivated Vaccine Revenue (2020-2021) (US$ Million)
Table 26. Europe Key Players COVID-19 Inactivated Vaccine Market Share (2020-2021)
Table 27. Europe COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 28. Europe COVID-19 Inactivated Vaccine Market Share by Type (2021-2027)
Table 29. Europe COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 30. Europe COVID-19 Inactivated Vaccine Market Share by Application (2021-2027)
Table 31. Japan Key Players COVID-19 Inactivated Vaccine Revenue (2020-2021) (US$ Million)
Table 32. Japan Key Players COVID-19 Inactivated Vaccine Market Share (2020-2021)
Table 33. Japan COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 34. Japan COVID-19 Inactivated Vaccine Market Share by Type (2021-2027)
Table 35. Japan COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 36. Japan COVID-19 Inactivated Vaccine Market Share by Application (2021-2027)
Table 37. Key Players in China
Table 38. Key Players in Southeast Asia
Table 39. Key Players in India
Table 40. Inovio Pharmaceuticals Company Details
Table 41. Inovio Pharmaceuticals Description and Business Overview
Table 42. Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Product
Table 43. Inovio Pharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 44. Inovio Pharmaceuticals Recent Development
Table 45. Takis Biotech (Evvivax) Company Details
Table 46. Takis Biotech (Evvivax) Description and Business Overview
Table 47. Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Product
Table 48. Takis Biotech (Evvivax) Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 49. Takis Biotech (Evvivax) Recent Development
Table 50. Zydus Cadila Company Details
Table 51. Zydus Cadila Description and Business Overview
Table 52. Zydus Cadila COVID-19 Inactivated Vaccine Product
Table 53. Zydus Cadila Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 54. Zydus Cadila Recent Development
Table 55. Codagenix, Inc. Company Details
Table 56. Codagenix, Inc. Description and Business Overview
Table 57. Codagenix, Inc. COVID-19 Inactivated Vaccine Product
Table 58. Codagenix, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 59. Codagenix, Inc. Recent Development
Table 60. GeoVax, Inc. Company Details
Table 61. GeoVax, Inc. Description and Business Overview
Table 62. GeoVax, Inc. COVID-19 Inactivated Vaccine Product
Table 63. GeoVax, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 64. GeoVax, Inc. Recent Development
Table 65. Bravovax Company Details
Table 66. Bravovax Description and Business Overview
Table 67. Bravovax COVID-19 Inactivated Vaccine Product
Table 68. Bravovax Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 69. Bravovax Recent Development
Table 70. Janssen Pharmaceutical Companies Company Details
Table 71. Janssen Pharmaceutical Companies Description and Business Overview
Table 72. Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Product
Table 73. Janssen Pharmaceutical Companies Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 74. Janssen Pharmaceutical Companies Recent Development
Table 75. Altimmune Company Details
Table 76. Altimmune Description and Business Overview
Table 77. Altimmune COVID-19 Inactivated Vaccine Product
Table 78. Altimmune Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 79. Altimmune Recent Development
Table 80. Vaxart Company Details
Table 81. Vaxart Description and Business Overview
Table 82. Vaxart COVID-19 Inactivated Vaccine Product
Table 83. Vaxart Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 84. Vaxart Recent Development
Table 85. CanSino Biologics Company Details
Table 86. CanSino Biologics Description and Business Overview
Table 87. CanSino Biologics COVID-19 Inactivated Vaccine Product
Table 88. CanSino Biologics Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 89. CanSino Biologics Recent Development
Table 90. ExpreS2ion Biotechnologies ApS Company Details
Table 91. ExpreS2ion Biotechnologies ApS Description and Business Overview
Table 92. ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Product
Table 93. ExpreS2ion Biotechnologies ApS Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 94. ExpreS2ion Biotechnologies ApS Recent Development
Table 95. Clover Biopharmaceuticals Company Details
Table 96. Clover Biopharmaceuticals Description and Business Overview
Table 97. Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Product
Table 98. Clover Biopharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 99. Clover Biopharmaceuticals Recent Development
Table 100. GSK Company Details
Table 101. GSK Description and Business Overview
Table 102. GSK COVID-19 Inactivated Vaccine Product
Table 103. GSK Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 104. GSK Recent Development
Table 105. Vaxil Bio Ltd. Company Details
Table 106. Vaxil Bio Ltd. Description and Business Overview
Table 107. Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Product
Table 108. Vaxil Bio Ltd. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 109. Vaxil Bio Ltd. Recent Development
Table 110. Generex Company Details
Table 111. Generex Description and Business Overview
Table 112. Generex COVID-19 Inactivated Vaccine Product
Table 113. Generex Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 114. Generex Recent Development
Table 115. Novavax, Inc. Company Details
Table 116. Novavax, Inc. Description and Business Overview
Table 117. Novavax, Inc. COVID-19 Inactivated Vaccine Product
Table 118. Novavax, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 119. Novavax, Inc. Recent Development
Table 120. Sanofi Pasteur Company Details
Table 121. Sanofi Pasteur Description and Business Overview
Table 122. Sanofi Pasteur COVID-19 Inactivated Vaccine Product
Table 123. Sanofi Pasteur Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 124. Sanofi Pasteur Recent Development
Table 125. Baylor Company Details
Table 126. Baylor Description and Business Overview
Table 127. Baylor COVID-19 Inactivated Vaccine Product
Table 128. Baylor Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 129. Baylor Recent Development
Table 130. iBio, Inc. Company Details
Table 131. iBio, Inc. Description and Business Overview
Table 132. iBio, Inc. COVID-19 Inactivated Vaccine Product
Table 133. iBio, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 134. iBio, Inc. Recent Development
Table 135. Moderna, Inc. Company Details
Table 136. Moderna, Inc. Description and Business Overview
Table 137. Moderna, Inc. COVID-19 Inactivated Vaccine Product
Table 138. Moderna, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 139. Moderna, Inc. Recent Development
Table 140. Curevac Company Details
Table 141. Curevac Description and Business Overview
Table 142. Curevac COVID-19 Inactivated Vaccine Product
Table 143. Curevac Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 144. Curevac Recent Development
Table 145. ImmunoPrecise Company Details
Table 146. ImmunoPrecise Description and Business Overview
Table 147. ImmunoPrecise COVID-19 Inactivated Vaccine Product
Table 148. ImmunoPrecise Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021
Table 149. ImmunoPrecise Recent Development
Table 150. COVID-19 Inactivated Vaccine Market Trends
Table 151. COVID-19 Inactivated Vaccine Market Drivers
Table 152. COVID-19 Inactivated Vaccine Market Challenges
Table 153. COVID-19 Inactivated Vaccine Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Inactivated Vaccine Market Share by Type in 2021 & 2027
Figure 2. In Clinical Trials Features
Figure 3. Out-of-Clinical Trials Features
Figure 4. Global COVID-19 Inactivated Vaccine Market Share by Application in 2021 & 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. COVID-19 Inactivated Vaccine Report Years Considered
Figure 9. Global COVID-19 Inactivated Vaccine Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 10. Global COVID-19 Inactivated Vaccine Market Share by Regions (2020-2027)
Figure 11. Global COVID-19 Inactivated Vaccine Market Share by Players in 2021
Figure 12. Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2021-2027)
Figure 13. Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2021-2027)
Figure 14. Global COVID-19 Inactivated Vaccine Revenue Market Share by Application in 2021
Figure 15. North America COVID-19 Inactivated Vaccine Market Size 2021-2027 (US$ Million)
Figure 16. Europe COVID-19 Inactivated Vaccine Market Size 2021-2027 (US$ Million)
Figure 17. Japan COVID-19 Inactivated Vaccine Market Size 2021-2027 (US$ Million)
Figure 18. COVID-19 Inactivated Vaccine Market Size in China (2021-2027) (US$ Million)
Figure 19. COVID-19 Inactivated Vaccine Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 20. COVID-19 Inactivated Vaccine Market Size in India (2021-2027) (US$ Million)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed
Keyplayers in Global COVID-19 Inactivated Vaccine Market Size, Status and Forecast 2022
Inovio PharmaceuticalsTakis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Bravovax
Janssen Pharmaceutical Companies
Altimmune
Vaxart
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
GSK
Vaxil Bio Ltd.
Generex
Novavax, Inc.
Sanofi Pasteur
Baylor
iBio, Inc.
Moderna, Inc.
Curevac
ImmunoPrecise